Last reviewed · How we verify

NCT05263544

Uterine Anatomical Flexion Degree ( Uterocervical Angle) and Intrauterine Device (IUD) Dislocation

Completed Last updated 5 June 2023
What this trial tests

trial testing measuring uterocervical angle and uterine dimensions in Contraception in 78 participants. Completed in 28 March 2023.

Timeline
30 June 2021
Primary endpoint
15 March 2023
28 March 2023

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment78
Start date30 June 2021
Primary completion15 March 2023
Estimated completion28 March 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 18 to 40, female only, with Contraception or Intrauterine Device Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators want to find numerical determination of the degree of anatomical anterior or posterior flexion of the uterus (uterocervical angle) at the intersection of both lines using a protractor, provided that straight lines are drawn from the middle of the cervical canal and the middle of the endometrial canal in cases where the intrauterine device is found to have dislocated and and cases with no dislocation. Investigators will also measure uterus size, uterine width, cervical canal length, endometrial canal length, endometrial canal width and compare the results in both groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Contraception

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05263544.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing